Why Older Adults Are Missing From Drug Trials

Clinical trials offer early access to new treatments, but older adults are frequently excluded from the research that shapes those therapies.

Dr. Rhea Rogers, a board certified physician, advises patients to shift their focus before enrolling in a study. She suggests moving away from the question of whether a trial will help an individual and instead asking what specific scientific problem the study is designed to solve. This approach helps participants understand the primary goal of the research.

Many people view clinical trials as a last resort option for those who have exhausted other medical choices. Rogers challenges this view, noting that participation provides immediate access to therapies and devices that will not be available to the general public for years. She describes this access as a major benefit of joining a study.

To find potential studies, Rogers recommends checking ClinicalTrials.gov, consulting with a primary care physician, or looking at academic centers and disease specific organizations that conduct their own research. Amy O Rourke, an aging expert, adds that the National Institutes of Health maintains a list of clinical trials and indicates which studies offer compensation to participants.

Participants must understand the mechanics of the study before signing up. O Rourke explains that individuals may receive a placebo rather than the experimental drug. She advises that the expectation should not be guaranteed improvement, but rather a willingness to contribute to the data collection process.

Beyond the medical aspects, participants often find value in the support systems provided by trial sites. O Rourke noted that clients who joined a local clinical trial group benefited from social workers and support groups. These resources connected older adults with community services they were previously unaware of, in addition to providing access to medical specialists.

The exclusion of older adults from research creates a gap in medical evidence. O Rourke has heard older patients described as evidence free because they are rarely included in studies. This lack of data makes it difficult to understand how treatments affect this demographic.

Gerontologist Sam Cradduck explains that medication metabolizes differently in older bodies compared to younger ones. Without older adults participating in trials, doctors lack the information needed to prescribe safely. Cradduck states that new medicines cannot be approved without going through the clinical trial process.

Cradduck also addresses the common fear of being a test subject. She clarifies that by the time a treatment reaches a clinical trial, it has already undergone repeated testing. While adverse effects can occur with any prescribed medication, the process is designed to ensure safety before broader approval.

The National Institutes of Health provides resources to help identify which trials offer financial compensation. This information allows individuals to weigh the logistical and financial aspects of participation against the potential medical benefits.